As of the most recent available WADA documentation, BPC-157 remains monitored rather than prohibited
10.1136/gutjnl-2015-310783 58 MoriN.SatoH.HayashibaraT.SenbaM.GeleziunasR.WadaA.et al (2003)
The production of ACPA is influenced by several factors, including genetics (specifically genes encoding HLA-DR/SEs/Shared epitopes), environmental elements, smoking habits, the presence of lymphoid-specific protein tyrosine phosphatase non-receptor type-22 (PTPN22), and certain infectious agents such as Porphyromonas gingivalis, Aggregatibacter Actinomycetemcomitans, and the Epstein-Barr virus
Therefore, parenteral cyanocobalamin should be administered to a pregnant woman if the benefits outweigh the risks.[15][16] Cyanocobalamin is excreted in the breast milk of nursing women in levels similar to the level of vitamin B12 in maternal plasma.[25] The distributed cyanocobalamin in breast milk has been found to be compatible with breastfeeding by the American Academy of Pediatrics.[26] In addition, there has not been any reports of adverse effects associated with the intake of normal daily requirements of vitamin B12 during lactation
Sublingual placement extends taste exposure time without pharmacokinetic benefit
BAC Water is the standard reconstitution solvent referenced in peptide research protocols and is compatible with the majority of lyophilised peptide compounds
